Cooperative Agreement NU62PS924826
- Federal Cooperative Agreement Summary Award Details: The Philadelphia Department of Public Health, Division of HIV Health, received a $579,853 Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940). The award was effective September 30, 2025, with an ultimate completion date of September 29, 2030. Products and Services: Under this five-year...
- The Executive Office of the Governor of Delaware, Division of Public Health received a $360,444 Cooperative Agreement from the National Center for HIV/AIDS under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944), effective September 30, 2025 through September 29, 2030. Under this award, Delaware's Division of Public Health will conduct comprehensive HIV surveillance and medical monitoring activities designed to track HIV...
- Summary The Pennsylvania Department of Health received a $999,342 Cooperative Agreement award from the National Center for HIV/AIDS (CFDA 93.940: HIV Prevention and Surveillance Activities-Health Department Based) effective September 30, 2025, through September 29, 2030. This award supports the Medical Monitoring Project (MMP), which conducts surveillance activities to collect behavioral and clinical data on probability samples of persons living with HIV. The project generates epidemiological...
- Cooperative Agreement Summary The City and County of San Francisco, Department of Public Health (SFDPH) received a $643,882 Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940), effective September 30, 2025, through September 29, 2030. The award funds the Medical Monitoring Project (MMP) in San Francisco, one of 23 national MMP sites, which...
- Federal Cooperative Agreement Summary The City of Philadelphia, through its Disease Control Division, received a $3.31 million Cooperative Agreement from the National Center for Immunization and Respiratory Diseases under the Immunization Cooperative Agreements program (CFDA 93.268) effective July 1, 2025 through June 30, 2030. This five-year award supports the Philadelphia Department of Public Health's (PDPH) Immunization Program in strengthening vaccine-preventable disease prevention and...
- The Puerto Rico Department of Health received a $378,602 Cooperative Agreement award from the National Center for HIV/AIDS (Centers for Disease Control and Prevention) under the Human Immunodeficiency Virus (HIV)/Acquired Immunodeficiency Syndrome (AIDS) Surveillance program (CFDA 93.944), effective September 30, 2025, through September 29, 2030. Under this agreement, the awardee will conduct comprehensive HIV/AIDS surveillance activities to track HIV incidence and prevalence throughout Puerto...
- Federal Grant Award Summary Public Health Management Corporation (PHMC) received a $872,358 Project Grant award from the Department of Housing and Urban Development's Assistant Secretary for Community Planning and Development under the Housing Opportunities for Persons with AIDS (HOPWA) program (CFDA 14.241), effective January 30, 2026, through January 29, 2029. This three-year award supports PHMC's comprehensive housing and supportive services delivery for low-income individuals living with...
- Federal Cooperative Agreement Summary Public Health Management Corporation (PHMC) received a $341,020 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the Injury Prevention and Control Research and State and Community Based Programs (CFDA 93.136) awarded September 30, 2025. The award funds evaluation of a publicly funded partial hospitalization program's impact on reducing overdose risk in Philadelphia, with performance extending through September 29, 2028....
- The Houston Department of Health and Human Services received a $1.46 million Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) National Center for HIV/AIDS under the HIV Prevention and Surveillance Activities-Health Department Based program (CFDA 93.940), awarded September 30, 2025, with performance through September 29, 2030. The award funds implementation of the Medical Monitoring Project (MMP), a surveillance initiative designed to collect representative...
- Federal Formula Grant Award Summary The U.S. Department of Housing and Urban Development's Assistant Secretary for Community Planning and Development awarded the City of Philadelphia's Division of Housing and Community Development $9.47 million under the Housing Opportunities for Persons with AIDS (HOPWA) program (CFDA 14.241) on September 22, 2025, for the three-year performance period ending September 21, 2028. This formula grant provides housing assistance, supportive services, program...
HIGH-IMPACT HIV PREVENTION AND SURVEILLANCE PROGRAMS FOR THE PHILADELPHIA DEPARTMENT OF PUBLIC HEALTH - THE CITY OF PHILADELPHIA REQUESTS COOPERATIVE AGREEMENT FUNDING UNDER CDC-RFA-PS-24-0047 HIGH-IMPACT HIV PREVENTION AND SURVEILLANCE PROGRAMS FOR HEALTH DEPARTMENTS TO SUPPORT COMMUNITY ENGAGEMENT, HEALTH EQUITY, SYNDEMIC AND WHOLE-PERSON APPROACHES TO HIV PREVENTION. PRIORITIES INCLUDE INCREASING KNOWLEDGE OF HIV STATUS, REDUCING HIV TRANSMISSION, PREVENTING NEW HIV INFECTIONS, IMPROVING LINKAGE TO CARE AND VIRAL SUPPRESSION, AND MAINTAINING ELIMINATION OF PERINATAL TRANSMISSION. OVER A 5-YEAR PERIOD BEGINNING AUGUST 1, 2024, THE CITY OF PHILADELPHIA, THROUGH ITS DEPARTMENT OF PUBLIC HEALTH (PDPH) DIVISION OF HIV HEALTH, PROPOSES TO IMPLEMENT A COMPREHENSIVE HIV PREVENTION AND SURVEILLANCE PROGRAM TO PREVENT NEW HIV INFECTIONS AND IMPROVE THE HEALTH OF PEOPLE WITH HIV. BY THE END OF THE PERIOD OF PERFORMANCE, REDUCED NEW HIV INFECTIONS, IMPROVED HEALTH OUTCOMES FOR PEOPLE WITH HIV INCLUDING SUSTAINED VIRAL SUPPRESSION, AND REDUCED HIV-RELATED HEALTH DISPARITIES ARE EXPECTED. WHILE NEW DIAGNOSES OF HIV IN PHILADELPHIA HAVE DECREASED BY 12.8% SINCE 2018, HIV DISEASE CONTINUES TO AFFECT THE CITY AT EPIDEMIC PROPORTIONS. CURRENTLY, NEARLY 19,000 PEOPLE WITH DIAGNOSED HIV LIVE IN PHILADELPHIA, AND DURING 2022, THERE WERE 382 NEW DIAGNOSES OF HIV. THE LARGEST BURDEN OF HIV DISEASE CONTINUES TO IMPACT MEN WHO HAVE SEX WITH MEN AND INCREASINGLY PEOPLE WHO INJECT DRUGS. OVERALL, BOTH NEWLY DIAGNOSED AND PREVALENT DISEASE DISPROPORTIONALLY AFFECT BLACK AND BROWN COMMUNITIES IN PHILADELPHIA. PDPH ESTIMATES A TOTAL OF 8,750 HIV NEGATIVE PERSONS IN PHILADELPHIA DURING 2022 WITH A PREP INDICATION, WITH HIV-NEGATIVE, NON-HISPANIC BLACK MSM AND HISPANIC MSM HAVING THE GREATEST PROPORTION OF PREP INDICATIONS (66% AND 48%, RESPECTIVELY). BECAUSE OF THE CITY'S HEAVY HIV BURDEN, PHILADELPHIA WAS DESIGNATED IN 2019 AS ONE OF THE INITIAL JURISDICTIONS ELIGIBLE FOR THE FEDERAL ENDING THE HIV EPIDEMIC (EHE) INITIATIVE. BY LATE 2020, A COMMUNITY PLAN TO END THE HIV EPIDEMIC IN PHILADELPHIA WAS PUBLISHED. THE EHE PLAN'S PRIMARY GOAL IS TO ACHIEVE A 75% REDUCTION IN NEW HIV DIAGNOSES BY 2025 AND A 90% REDUCTION IN NEW HIV DIAGNOSES BY 2030. LOCALLY, ACTIVITIES ARE CENTERED ON THE NATIONAL EHE STRATEGIES TO DIAGNOSE, TREAT, PREVENT, AND RESPOND TO OUTBREAKS, AS WELL AS LOCALLY-DEVELOPED HEALTH EQUITY AND RADICAL CUSTOMER SERVICE ACTIVITIES NECESSARY TO MEET EHE GOALS. THE EHE PLAN ALIGNS WITH THE PHILADELPHIA ELIGIBLE METROPOLITAN AREA INTEGRATED HIV PREVENTION AND CARE PLAN 2022-2026, A REQUIREMENT OF THE RYAN WHITE HIV/AIDS PROGRAM FOR THE 9-COUNTY REGION. THROUGH IMPLEMENTATION OF ALL REQUIRED PS24-0047 STRATEGIES AND ACTIVITIES, PDPH AIMS TO ENSURE THAT ALL UNDIAGNOSED INDIVIDUALS ARE AWARE OF THEIR HIV INFECTION, ENSURE THAT ALL HIV-DIAGNOSED PERSONS ARE RAPIDLY LINKED TO AND RETAINED IN HIV MEDICAL CARE, THAT PATIENTS IN HIV CARE ARE SUPPORTED IN ACHIEVING AND MAINTAINING VIRAL SUPPRESSION, AND THAT NEW HIV INFECTIONS ARE AVOIDED THROUGH NPEP, PREP, CONDOM PROMOTION, ACCESS TO LOCALLY-FUNDED SYRINGE SERVICE PROGRAMS, AND OTHER RISK REDUCTION STRATEGIES.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 3/5/26 | ||
| Not listed | $0 | 11/17/25 | ||
| Not listed | $0 | 11/17/25 | ||
| Not listed | $3.2m | 6/25/25 | ||
| Not listed | $4.8m | 6/25/25 |